Product Program year 2025 Source: CMS Open Payments

EndoClot SIS

Device EndoTherapy

PDI 16972011720240

Open in the dashboard

General payments

$2,376,436

447 payments

Research payments

$0

0 payments

Through program year 2025, $2,376,436 in general payments and $0 in research payments were reported against EndoClot SIS (EndoTherapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $695,404 108
2024 General $1,190,413 131
2023 General $355,365 140
2022 General $135,254 68

Breakdown

Who paid General payments · program years 2022–2025
  1. Olympus Corporation of the Americas $2,316,410 49 payments
  2. Olympus America Inc. $60,026 398 payments
Top recipients General payments · program year 2025
  1. Adventhealth Orlando Teaching hospital · FL $570,849 82% · 1 payment
  2. Mercy Medical Center Teaching hospital · MD $92,959 13% · 1 payment
  3. Jennifer Davids Colon & Rectal Surgery · Boston, MA $9,360 1% · 9 payments
  4. Olga Beresneva Colon & Rectal Surgery · Boston, MA $7,746 1% · 9 payments
  5. Christopher Huang Gastroenterology · Boston, MA $6,923 <1% · 9 payments

The top 5 of 70 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Colon & Rectal Surgery $17,131 54% · 3 practitioners
  2. Gastroenterology Internal Medicine $13,828 44% · 47 practitioners
  3. Surgery $158 <1% · 6 practitioners
  4. Nurse Practitioner $144 <1% · 2 practitioners
  5. Emergency Medicine $81 <1% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $570,921 82% · 2 recipients
  2. Maryland $92,959 13% · 1 recipient
  3. Massachusetts $24,135 3% · 7 recipients
  4. New York $4,961 <1% · 14 recipients
  5. Indiana $607 <1% · 7 recipients

The top 5 of 21 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

447 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record